{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-207806","form_type":"8-K","ticker":"CMPX","cik":"0001738021","company_name":"Compass Therapeutics, Inc.","filed_at":"2022-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.864911+00:00","generated_at":"2026-06-24T06:34:16.087314+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Compass Therapeutics enters ATM with Jefferies for up to $75M; terminates B. Riley facility","bullets":["Enters Open Market Sale Agreement with Jefferies to sell up to $75M of common stock via ATM offering.","Prior ATM agreement with B. Riley Securities terminated effective July 29, 2022.","Jefferies receives up to 3% commission and up to $75K expense reimbursement; Compass not obligated to sell.","Sales will be made under effective S-3 registration statement (333-257821) and prospectus supplement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-207806","json":"https://secwatch.observer/filing/0001193125-22-207806.json","markdown":"https://secwatch.observer/filing/0001193125-22-207806.md","text":"https://secwatch.observer/filing/0001193125-22-207806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1738021/000119312522207806/0001193125-22-207806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1738021/000119312522207806/d379291d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:34:16.087314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}